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Abstract. Newly synthesized MHC class II molecules 
are sorted to lysosomal structures where peptide load- 
ing can occur. Beyond this point in biosynthesis, no 
MHC class II molecules have been detected at loca- 
tions other than the cell surface. We studied this step in 
intracellular transport by visualizing MHC class II mol- 
ecules in living cells. For this purpose we stably ex- 
pressed a modified HLA-DR1 13 chain with the Green 
Fluorescent Protein (GFP) coupled to its cytoplasmic 
tail (13-GFP) in class II-expressing Mel JuSo cells. This 
modification of the class II 13 chain does not affect as- 
sembly, intracellular distribution, and peptide loading 
of the MHC class II complex. Transport of the class II/ 
13-GFP chimera was studied in living cells at 37°C. We 
visualize rapid movement of acidic class II/13-GFP con- 
taining vesicles from lysosomal compartments to the 
plasma membrane and show that fusion of these vesi- 
cles with the plasma membrane occurs. Furthermore, 
we show that this transport route does not intersect the 
earlier endosomal pathway. 
M 
HC class II molecules present peptides to CD4 ÷ 
T cells. Most bound peptides are derived from 
antigens degraded in the endosomal pathway. 
To allow  association with these peptides, class II mole- 
cules are targeted to endosomal compartments by the in- 
variant chain (or Ii) 1  (7, 8). Here, Ii is degraded and Ii-degra- 
dation products are exchanged with antigenic peptides, a 
process catalyzed by HLA-DM (11, 41, 47, 48). The endo- 
somal compartments where class II molecules are loaded 
with peptide may be considered "special" lysosomes with 
a  multilamellar  and/or  multivesicular  appearance  and 
were originally termed MIIC for MHC class II--containing 
compartments (31). This "unique" morphology appears to 
be induced by the expression  of class II molecules (4). Al- 
though earlier endosomal compartments have been noted 
as "specialized class II loading compartments" as well (1, 
50), HLA-DM and class II molecules are generally located 
in compartments with lysosomal proteins like CD63, lamp-l, 
and cathepsin D (13, 24, 32, 42). 
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1. Abbreviations used in this paper. DGE, density gradient electrophore- 
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II-containing compartment; NRS, normal rabbit serum; PNS, postnuclear 
supernatant; TfR, transferrin receptor. 
How class  II molecules are  subsequently transported 
from MIIC to the plasma membrane is unclear, but they 
may use the existing endosomal pathway in a retrograde 
direction.  In this case, class II molecules would be able to 
associate with antigenic fragments in early endocytic struc- 
tures before cell surface appearance. Alternatively, MHC 
class  II  molecules could  be  transported  to  the  plasma 
membrane without employing the early endosomal recy- 
cling machinery. Class II molecules would then be trans- 
ported to the plasma membrane as if they were contained 
in secretory granules. Although secretion of such granules 
is tightly regulated, no such  mechanisms have been de- 
scribed for class  II molecules; Transport intermediates 
between MIIC and the cell surface have never been visual- 
ized.  These may be below detection levels  of the tech- 
niques used either due to continuous transport of small 
quanta of class II molecules from MIIC, or to the very 
transient existence  of intermediate structures.  Recently, 
Raposo  et  al.  (37) reported  the  association  of  MIIC- 
derived vesicles with the plasma membrane. This is the 
first indication of direct secretion of MIIC-compartments. 
To directly visualize these transport processes, we have 
constructed  a  chimeric  molecule  containing the  Green 
Fluorescent Protein (GFP) attached to the cytoplasmic tail 
of the class II 13 chain of HLA-DR1 (13-GFP) and stably 
transfected the human melanoma cell line Mel JuSo. Mel 
JuSo cells express functional class II HLA-DR3 molecules 
and all components required for efficient peptide loading 
of class II molecules (33, 42). The distribution and trans- 
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cells by confocal microscopy. We show that MHC class II/ 
13-GFP concentrate in acidic MIIC vesicles in the perinuclear 
region. These vesicles rapidly migrate towards the plasma 
membrane, without intersection of earlier endosomes, and 
ultimately fuse with the plasma membrane. We thus visu- 
alize  a  direct  vesicular  transport  route  from lysosomal 
MIIC structures to the plasma membrane. 
Materials and Methods 
Antibodies 
mAb anti-human CD63 (53), or 435 (21), mAb anti-human lamp-l: BB6 
(5), mAb anti-human DMA: 5C1 (43), mAb anti-Ii luminal portion: Bu45 
(55),  mAb anti-human transferrin receptor: 66Ig10  (52), rabbit anti-rab7 
serum (a kind gift from Dr. P. van der Sluys, University of Utrecht, Utrecht, 
The Netherlands), rabbit anti-human cathepsin D serum (a kind gift from 
Dr. J.M. Tager and H. Aerts, University of Amsterdam, Amsterdam, The 
Netherlands), rabbit anti-class II DR-I~ chain serum (26), mAb anti-human 
HLA class I complex: W6/32 (29), mAb anti-human HLA class I heavy 
chain: HC-10 (49), mAb anti-human HLA class II complex: Tu36  (46), 
rabbit anti-rGFP serum (Clontech, Palo Alto, CA) and Texas red (TxR)- 
conjugated secondary antibodies (Molecular Probes, Leiden, The Nether- 
lands). For immunofluorescence detection the antibodies were diluted in 
phosphate-buffered saline containing 0.5% BSA. 
Construction of the HLA-DRI [3-GFP  and Transfection 
The cDNA of GFPS65T (9, 17) was kindly obtained from R. Tsien (Uni- 
versity of California, San Diego, CA) and subcloned into pcDNA3 (Invi- 
trogen, San Diego, CA). A fusion construct was generated by PCR creat- 
ing immediate upstream HindlII-ClaI sites in the GFP cDNA (using oligo 
5'  TTCAAGAAGAGGAAATGATAGCTATFCGAACCG  and  SP6 
(Invitrogen) and  a  downstream ClaI  site in  DR131 eliminating its stop 
codon  (using  5'  GGTTGTCCTAAGGACTCGCGTTAGCTAATATC 
and T7 (Invitrogen). The GFP portion was cloned into pcDNA3 by Hind- 
III-BamHI digest and the DR131 portion was fused upstream in frame us- 
ing  the  ClaI  site.  The  coding region  of the  HLA-DR131  portion  was 
checked by sequence analysis. 
Mel JuSo cells were transfected using the Calcium Phosphate precipita- 
tion  procedure  and  selected in  DMEM  (GIBCO-BRL,  Gaithersburg, 
MD) supplemented with G418  (1  v~g/ml, GIBCO). Positive clones were 
selected for fluorescent appearance and maintained in Iscoves medium 
(GIBCO) supplemented with G418 (500 v.g/l). 
Confocal Analysis 
For immunofluorescence labeling, ceils were fixed in ice-cold methanol 
and incubated with various antibodies and Texas red-conjugated second- 
ary antibodies. 
Living cells were analyzed in a tissue-culture device at 37°C. Cells were 
cultured in Hepes-buffered Iscoves medium supplemented with 10% FCS 
for at least 18 h before and during the confocal analysis. The temperature 
of the medium was continuously checked during analysis. 
Ceils were cultured for 4.5 h  in the presence of 5 p.g/ml Brefeldin A 
(BFA; Sigma Chemical. Co., St. Louis, MO) or for 3 h in the presence of 
100 IxM chloroquine (Sigma). Alternatively, cells were incubated for 1 min 
before analysis with LysoTracker Red DND99 at a concentration of 300 nM. 
Endosomes were labeled by internalization of Texas red (TxR; 25 p.g/ml) 
or sulforhodamine 101 (SR101;  25 p.g/ml). 
Confocal analyses were performed using a 600MRC equipped with an 
Argon/Krypton laser (BioRad Labs, Hercules, CA). Green fluorescence 
was detected at h>515 nm after excitation at h =  488 rim. For dual analy- 
ses, green fluorescence was detected at h 520--560 nm. Red fluorochromes 
(Sulforhodamine 101, Texas  red  and  LysoTracker  Red  DND99),  pur- 
chased from Molecular Probes (Leiden, The Netherlands) were excited at 
k = 568 nm and were detected at h>585 rim. Vesicular transport was visu- 
alized by first collecting images at short intervals. Then, images were su- 
perimposed and the first and last image of the series were subtracted from 
the resulting picture, using the program Comos (BioRad). The resulting 
subtraction is shown in yellow in conjunction with the first and last image 
in green or red. 
Electron Microscopy 
Mel JuSo cells were fixed in either a mixture of 4% formaldehyde (wt/vol) 
and 0.1%  (vol/vol) glutaraldehyde in 0.1  M  phosphate buffer (pH 7.2) 
(Figs. 4 A  and 6 A) or only 4% formaldehyde (Fig. 4 B). Ultrathin cryo- 
sections were subsequently incubated with anti-CD63 (mAb 435)  and ei- 
ther the rabbit anti-class II 13 chain or the rabbit anti-GFP sera followed 
by either goat anti-rabbit IgG or goat anti-mouse IgG finked to 10- or 5-nm 
gold particles, respectively (Amersham, 's-Hertogenbosch, The Nether- 
lands). The sections were subsequently embedded in a mixture of methyl- 
cellulose and uranyl acetate and examined with a CM10 electron micro- 
scope (Philips Electronic Instruments, Eindhoven, The Netherlands). 
Figure  1.  Distribution  of 
class II/f3-GFP in living cells. 
The  melanoma  cell line  Mel 
JuSo  was  stably  transfected 
with  a  construct  containing 
GFP coupled to the cytoplas- 
mic  tail  of the  class  II  DR1 
[3-chain and analyzed by con- 
focal  microscopy  in  a  tissue 
culture chamber at 37°C. (A) 
Distribution of class II/13-GFP. 
Fluorescence  is  observed  at 
the plasma membrane and is 
found  accumulated  in  multi- 
ple vesicles in the perinuclear 
region. The nucleus is devoid 
of  fluorescence.  Note  the 
presence  of  vesicles  in  the 
periphery of the cell. (B) Dis- 
tribution  of  class  II/I3-GFP 
after  4.5  h  incubation  with 
BFA  to  inhibit  transport 
from the ER. Class II/13-GFP 
containing vesicles disappear and fine-reticulate (ER), as well as cell surface fluorescence is observed. (C) Chloroquine causes swelling 
of the 13-GFP containing vesicles. The transfectants were incubated with chloroquine for 3 h. As a result, the fluorescent vesicles appear 
as large swollen structures while class II molecules remain present at the plasma membrane. Bar, 10 wm. 
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SubceUularfractionation by density gradient electrophoresis  (DGE).  Mel JuSo 
cells were incubated for 30 min with horseradish peroxidase (HRP, type 
VIA; Sigma) at a concentration of 2 mg/ml at 37°C, as described (51). 
Cells were washed three times with PBS (0°C), removed from the culture 
dish by scraping in homogenization buffer (10 mM triethanolamine, 10 
mM acetic acid, 1 mM EDTA, 0.25 M sucrose,  pH 7.4) and collected by 
centrifugation (139 g, 7 min). Cells were homogenized by passing 10-15 
times through a 22-G  x  1.5 needle and postnuclear supernatant (PNS) 
was collected by centrifugation at 840 g for 15 rain. The PNS was treated 
with trypsin (25 Ixg/mg total protein) for 5 rain at 37~C, trypsin inactivated 
(100 p~g soybean trypsin inhibitor/nag total protein and 1 mM PMSF) and 
vesicles collected (100,000 g for 1 h at 4°C). Vesicles were separated by a 
DGE  device  with an extended electrophoretic pathway of 7 cm,  as de- 
scribed (51). Electrophoresis was performed at 10.30 mA constant current 
for 80 rain. Fractions of 250 ILl were collected starting at the anodic site. 
Proteins were collected by TCA-precipitation and analyzed by Western 
blotting after separation by 10%  SDS-PAGE.  HRP activity  was deter- 
mined spectrophotometrically at 455 nm using O-dianisidine as a  sub- 
strate (16). [3-Hexosaminidase  activity was determined spectrophotomet- 
rically at 405 nm using p-nitrophenyl-N-acetyl-[3-D-glucosaminide  (Sigma) 
as a substrate, (22). 
Biochemical analysis of surface class H molecules. A  10-cm dish of Mel 
JuSo cells or Mel JuSo cells expressing [3-GFP was labeled at 4°C using 
lactoperoxidase-catalyzed  iodination with 400  p~Ci Na12SI. Cells  were 
washed four times with PBS (0°C) and lysed in NP-40 containing lysis mix- 
ture. Nuclei were removed (5 min, 12,000 g) and the lysate precleared with 
normal rabbit serum (NRS). The lysate was split and immunoprecipitated 
with NRS, Tu36,  anti-class II [3 serum or W6/32, respectively.  The Tu36 
isolate was further split and incubated in nonreducing sample buffer at 
room temperature or at 95°C before separation by 10% SDS-PAGE. The 
other isolates were analyzed by SDS-PAGE after incubation in reducing 
sample buffer at 95°C. 
Figure 2.  Biochemical analysis of endogenous and  13-GFP con- 
taining class II molecules. (tl) Subcellular distribution of 13-GFP 
in transfected Mel JuSo cells. Cells were labeled by fluid phase 
uptake of HRP for 30 min, and postnuclear supernatant was ob- 
tained  and  fractionated  in an electric field by density gradient 
electrophoresis. The enzymatic activity of HRP (closed circles) and 
of 13-hexosaminidase (open circles) were determined in alternate 
fractions. Proteins in the even fractions were collected by TCA- 
precipitation and  analyzed by SDS-PAGE  and subsequent im- 
munoblotting. The distribution of 13-GFP and endogenous 13-chain 
were determined by probing the immunoblots with an anti-class 
II  13-chain serum. The position of HLA class I  molecules, DM, 
and cathepsin D  (cat D) was determined by incubating the same 
immunoblot with different antibodies. The position of the three 
forms of cathepsin D  (pre-, pro-, and mature form) are indicated. 
(B) Biochemical analysis of cell surface class II molecules. Radio- 
iodinated Mel JuSo ceils or transfectants expressing 13-GFP (bot- 
tom lanes +) were lysed followed by immunopreeipitation with 
Results 
Distribution of GFP-tagged Class H Molecules 
in Living Cells 
Mel JuSo cells express endogenous class II molecules and 
all components to efficiently load class II molecules with 
peptides (including HLA-DM; [42, 51]). In addition, these 
cells are adherent which is instrumental  in  our real-time 
confocal analyses. Mel JuSo cells were transfected with a 
chimera of the HLA-DR1  p-chain with GFP attached to 
the cytoplasmic tail (p-GFP). Since GFP is a bulky fluores- 
cent protein, it may interfere with correct assembly and in- 
tracellular distribution of the chimeric class II/p-GFP mol- 
ecules. However, the distribution of green fluorescence in 
the transfectants cultured and analyzed at 37°C was as ex- 
pected for endogenous class II molecules (Fig. 1). Green 
fluorescence is observed at the plasma membrane and in 
numerous vesicles that are concentrated in the perinuclear 
either normal rabbit serum (NRS),  anti-class II mAb Tu36,  an 
antiserum that recognizes free class II p-chains (lanes 13), or anti- 
class I  mAb W6/32, respectively. The Tu36 isolate was split and 
analyzed after incubation with SDS at either room temperature 
(lanes NB)  or after boiling (lanes B). Immunoprecipitates were 
analyzed by 10% SDS-PAGE and the positions of the markers and 
13-GFP are indicated. Surface class II molecules are isolated from 
control cells while the 13-GFP expressing cells mainly contained 
surface class II/13-GFP. Both control class II and class II/13-GFP 
are observed in an SDS-stable compact conformation migrating 
at 54 kD  and 75 kD, respectively (lanes NB).  These complexes 
dissociate upon boiling (lanes B). Note that free class II 13- or 13-GFP 
chains cannot be recovered from the cell surface (lanes 13). 
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fixed  13-GFP-transfected 
cells. Mel JuSo cells fixed in 
ice-cold  methanol  and 
stained  with  antibodies 
against the indicated  marker 
proteins and Texas red-con- 
jugated  secondary  antibod- 
ies, were analyzed  by confo- 
cal  microscopy.  The  images 
shown  were  obtained  by 
merging  the  green  image, 
corresponding to 13-GFP, and 
the red image, corresponding 
to immunodetected markers. 
Colocalization  is seen in yel- 
low due to the combination of 
the green  and  the  red signal. 
Perinuclear 13-GFP  containing 
vesicles were positive for the 
MIIC  markers  CD63  (A), 
lamp-1  (B),  and  HLA-DM 
(C). Ii (D) was detected with 
an antibody directed against 
the luminal portion of the Ii. 
The antibody only stained  a 
fraction  of  the  perinuclear 
13-GFP  containing  vesicles. 
(E) Immunodetection of the 
transferrin receptor (TfR) to 
label plasma membrane and 
early endosomes showed  no 
colocalization between 13-GFP 
and the TfR in intracellular 
vesicles.  (F)  Most  of  the 
13-GFP  containing  vesicles 
were positive for the late en- 
dosome-associated  GTPase 
rab7. (Optical sections: 1 ixm; 
magnification,  1200; Bar,  10 
~m.) 
region where the nucleus is indented  (Fig. 1 A). No fluo- 
rescence was observed with nontransfected Mel JuSo cells 
(not shown). The perinuclear location of 13-GFP in vesicles 
is consistent with the distribution of MIIC as observed by 
immuno-electron microscopy (31, 32) (see Fig. 4). 
To show that the fluorescent vesicles contain newly syn- 
thesized class II/13-GFP in transit to the plasma membrane, 
transport from the ER was inhibited by culture in the pres- 
ence of BFA (20) (Fig. 1 B). Peripheral vesicles were not 
derived from the constitutive secretory pathway since no 
effect on  the  intracellular  distribution  of class II/13-GFP 
was observed after 1.5  h  (not  shown).  However, fluores- 
cent vesicles had disappeared after a 4.5-h BFA treatment 
and intracellular fluorescence appeared dispersed over the 
cytoplasm (Fig.  1 B).  This fluorescence pattern  suggests 
that class II/13-GFP is retained in the ER by BFA treat- 
ment and the perinuclear vesicles obtained class II/13-GFP 
from the biosynthetic pathway. Class II molecules in Mel 
JuSo cells (data not shown), but also in B cells (31, 26) re- 
quire about 4 h  for quantitative plasma membrane expo- 
sure. 
To  test  whether  the  [3-GFP  containing  compartments 
are acidic, as expected for MIIC compartments (31), cells 
were treated with the weak base chloroquine. Chloroquine 
raises the lysosomal pH and causes swelling of the acidic 
compartments (10, 45), which is indeed observed for the 
I3-GFP containing vesicles (Fig. 1 C). 
IntraceUular Distribution  and Peptide Loading of 
Class III[3-GFP 
We next performed subceUular fractionation in an electric 
field by DGE (13, 42, 51) in order to determine whether 
the intracellular distribution  of class II/13-GFP resembled 
that of endogenous  class II molecules (Fig. 2 A). Trans- 
fected Mel JuSo cells were cultured in the presence of the 
fluid phase endocytosis marker HRP for 30 min to label 
the endosomes. After fractionation, the HRP and 13-hex- 
osaminidase activities were determined to position the en- 
dosomes and lysosomes, respectively (upper panel). Two 
endosomal populations are visualized by the HRP activity; 
early endosomes located around fraction 36,  and late en- 
dosomes around fraction 14, as described (51). Proteins in 
the  even  fractions  were  collected  by TCA-precipitation 
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CD63-containing  multivesicular  and 
multilamellar compartments. Mel JuSo 
cells  transfected  with  13-GFP were 
fixed  and  sections  were  labeled  with 
anti-CD63 (5 nm gold) and anti-class II 
13 chain  antibodies  (10 nm gold, A) or 
anti-GFP antibodies (10 nm gold,  B). 
The inset shows a higher magnification 
of  the  multivesicular  compartments 
shown by an asterisk.  G, Golgi; n, nu- 
cleus.  (Filled arrow) Multivesicular 
compartment;  (open arrow)  multila- 
mellar compartment. Inset:  (large ar- 
rows) anti-13 chain or anti-GFP; (small 
arrow) anti-CD63. The class II [3 chain 
and GFP are observed in  CD63-posi- 
tive  multivesicular  and  multilamellar 
structures.  Bar, 100 nm. 
and the distribution of various proteins was determined by 
Western  blot  analysis  (lower panels).  Class  I  molecules 
were observed in fractions 36-48, thereby positioning the 
ER and the plasma membrane. Immature HLA-DMA is 
found at the position of the ER (fraction 34-44)  (42) and 
mature HLA-DM at the position of late endosomes and 
lysosomes (fractions 6-24). Mature cathepsin D  is distrib- 
uted in a similar fashion as the 13-hexosaminidase activity. 
Most importantly, endogenous class II 13 (,-~30 kD), as well 
as the 13-GFP chain (~55 kD; GFP adds 25 kD), codistrib- 
uted  at  the  position  of class  I  molecules  (the  ER  and 
plasma membrane, fractions 34-46) and at the position of 
late  endosomal/lysosomal  fractions  that  also  contained 
mature HLA-DM (fractions 6-24). 
To exclude that addition of GFP to the cytoplasmic tail 
of the class II 13 chain has any effect on the ability to as- 
semble and mature into a proper peptide-binding class II 
complex, control  and  13-GFP  transfected  Mel  JuSo  cells 
were surface iodinated  and  analyzed for the presence of 
plasma membrane embedded SDS-stable class II dimers 
(Fig. 2 B). Class II complexes (lanes Tu36), free class II 13 
chains  (lanes  [3) or class I  molecules (lanes  W6/32) were 
immunoprecipitated.  The class II isolates were  split and 
analyzed by SDS-PAGE after incubation in SDS followed 
either by boiling (lanes B) or by incubation at room tem- 
perature (lanes NB). A  portion of peptide-loaded class II 
molecules will not  dissociate  under  the  latter  conditions 
and remain in a so-called compact form (14,  38, 39) (Fig. 2 
B). In control cells, a large fraction of class II molecules is 
in this compact form (migrating at 54 kD). In the 13-GFP 
transfectants,  class  II  is  largely  a  class  II/13-GFP  het- 
erodimer at the plasma membrane and for a major part in 
a compact configuration (now migrating at 75 kD). 
Characterization of Class IIIfl-GFP Containing 
Vesicles by Confocal and Immuno-Electron Microscopy 
To  further  establish  that  the  class  II/13-GFP containing 
vesicles represent MIIC compartments, the  transfectants 
were fixed and stained with antibodies against markers for 
MIIC (lamp-l, CD63, cathepsin D, HLA-DMA) (31, 42) 
and  for  the  plasma  membrane  and  early  endosomes 
(transferrin  receptor  [TfR]).  In  addition,  we  localized 
rab7, a small GTPase cosedimenting with class II-contain- 
ing  structures  (36)  and  late  endosomes  (12).  Lamp-l, 
CD63, HLA-DM, and rab7 all showed colocalization with 
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(Fig. 3, A-C, and F). A similar picture was seen for cathep- 
sin D (not shown). As expected, vesicles are found that are 
exclusively labeled for the marker proteins, since class II 
molecules are only observed in a subfraction of lysosomes 
(13, 31, 36). The MIIC marker proteins were not detected 
at the plasma membrane. Finally, the invariant chain (Ii) 
was detected with an antibody against the luminal portion 
of Ii. Ii colocalized with class II/13-GFP in the nuclear en- 
velope due to the retention of a relative large fraction of Ii 
in the ER  and the continous synthesis of novel 13-GFP. 
Furthermore, the antibody only labeled some 13-GFP con- 
taining peripheral  vesicles  (Fig.  3  D),  since the  luminal 
portion of Ii is rapidly degraded during transport in endo- 
somal compartments (32,  33).  Ii was not observed at the 
plasma membrane. 
To analyze whether (part of) the 13-GFP containing vesi- 
cles correspond to early endosomes, the fixed cells were 
labeled  with  anti-transferrin  receptor  (TfR)  antibodies. 
Class II/13-GFP and TfR colocalized at the plasma mem- 
brane,  although  TfR  mainly in  patches.  Intracellularly, 
TfR and class II/13-GFP labeled distinct vesicles (Fig. 3 E), 
in agreement with subceUular fractionation experiments (13). 
Thus, the perinuclear class II/13-GFP containing vesicles 
are acidic, contain various late endosomal/lysosomal mark- 
ers, and are distinct from early endosomes, suggesting that 
these vesicles are actual MIIC structures. 
To confirm the colocalization with MIIC markers and to 
resolve the ultrastructure of the  13-GFP containing vesi- 
cles, transfectants were analyzed by immuno-electron mi- 
croscopy (Fig. 4). Sections were labeled with antibodies di- 
rected against CD63  (5  nm gold) and either against the 
class II 13 chain (Fig. 4 A) or GFP (Fig. 4 B) (both 10 nm 
gold). Class II molecules colocalized with CD63 in multi- 
vesicular (closed arrow) and multilameUar structures (open 
arrow) near the Golgi (Fig. 4 A) and were present at the 
cell  surface  (not  shown).  Anti-GFP  antibodies  stained 
identical intracellular structures as anti-class II 13 chain an- 
tibodies (Fig. 4 B). 
In summary, the  13-GFP chimera efficiently assembles 
into class II-Ii complexes (not shown), obtains a peptide- 
loaded configuration, and has the normal intraceUular dis- 
tribution as read  biochemically and immunohistochemi- 
cally. In addition, the kinetics of compact or SDS-stable 
class II complex formation is unaltered (not shown). Thus, 
the addition of GFP to the cytoplasmic tail of the class II 13 
chain does not affect assembly, intracellular transport, dis- 
tribution, and peptide loading of class II molecules. 
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grate  from  the  perinuclear 
region  to  the  plasma  mem- 
brane  without  intersecting 
endosomal structures. Living 
13-GFP  transfected  cells 
were  observed  by  confocad 
microscopy at 37°C and  im- 
ages were  collected  every 5 
(A) or 3 (B, C, and D) s for a 
period of 5 or 1 min, respec- 
tively. Upper and lower pan- 
els  correspond  to  the  first 
and the last image of the se- 
res. The middle panel shows 
merged  images  of the  first 
and last image (green or red) 
and movement within the im- 
aging period is shown in yel- 
low.  (A)  13-GFP migration 
within a 5-min window. Yel- 
low trails are formed by mi- 
grating  vesicles. (B)  Migra- 
tion  recording  after  Texas 
red (TxR) uptake. Cells were 
incubated  with  TxR  for  10 
min  at  37°C, washed, and 
chased  for an  additional  14 
min. Images  were  collected 
of both the GFP (green) and 
the TxR signal (red). Identi- 
cad positions in the cells are 
indicated  by  arrows. Note 
that the TxR-labeled endoso- 
mad  structures  hardly  alter 
during the  1-min image col- 
lection. They are structurally 
different  from  the  13-GFP 
containing vesicles and (yellow)  trails. (C) Migrating class II/13-GFP  containing vesicles are part of the endocytic pathway. The transfec- 
tants were cultured with the red fluorochrome sulforhodamine 101 (SR101) for 30 min, followed by washing and subsequent chasing for 
another 30 min. Endocytosed material (red) and t3-GFP (green) showed a similar pattern. Rapidly moving vesicles are observed in the 
overlays that contain both 13-GFP and SR101. (D) Both perinuclear and peripheral moving ~-GFP labeled vesicles are acidic. Transfec- 
tants were incubated  with the acidophilic fluorochrome  LysoTracker Red (red) for 1 min and migration patterns  were obtained  as 
above. Arrows denote moving (yellow)  acidic 13-GFP  containing vesicles. (Optical sections: 2 t~m; Bar, 10 p.m.) 
Transport of Class IIIfl-GFP Containing Vesicles and 
Endosomes in Living Cells 
To visualize transport of class II molecules from the peri- 
nuclear region to the plasma membrane, the 13-GFP trans- 
fectants were cultured at 37°C  and confocal images were 
made every 5 s for 5 min (Fig. 5 A). The first and last im- 
age is shown in the upper and lower panel, respectively. 
To directly visualize vesicle motion, the 60 images were su- 
perimposed and the first and last were subtracted (middle 
panel). The image shown is a merge of the subtracted im- 
age (yellow)  and a combined first and last image (green). 
The  subtraction  procedure  selectively  visualizes  move- 
ment. Clearly, within the 5-min period, a number of vesi- 
cles were released from the perinuclear region and moved 
towards the plasma membrane (Fig. 5 A). The position of 
the perinuclear vesicles and the plasma membrane hardly 
alters within this timespan. 
To  determine  whether  class  II  molecules  are  trans- 
ported to the cell surface using the endocytic route in a 
retrograde fashion or in a manner independent of the en- 
dosomal route, cells were  allowed to internalize  the red 
fluorochromes Texas  red  (TxR)  or  Sulforhodamine  101 
(SR101) for various periods to label the endocytic path- 
way (Fig. 5, B and C). Transport of 13-GFP and fluid phase 
marker-containing  vesicles  was  followed  by  generating 
confocal images every 3 s for a total of 60 s. Again, the first 
and last images are shown in the upper and lower panel 
and the middle panel visualizes movement as described for 
Fig. 5 A. Both the green 13-GFP signal (left panel,  GFP) 
and the red signal (right panel, TxR or SR101) are shown. 
First, endosomes were labeled by culturing the cells for 
10 min with TxR followed by a chase period of 14 min, and 
intracellular  transport  of  13-GFP containing  vesicles  vs 
TxR-labeled endosomes was visualized in a  60-s  window 
(Fig. 5 B). By DGE, fluid phase markers have been shown 
to enter early and late endosomes of Mel JuSo cells within 
this timespan (13, 51). Endosomal structures were labeled 
by TxR in a similar region in the cell where ~3-GFP accu- 
mulated but the  structures clearly have a  different mor- 
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perinuclear class II/13-GFP vesicles hardly move within the 
1-min time span  (middle panel). However, some  13-GFP 
containing vesicles are rapidly moving in the periphery of 
the cell. Importantly, these vesicles migrate in an area de- 
void of TxR-labeled endosomal structures (arrows point at 
trails of moving ~-GFP containing vesicles and identical 
positions  in  the  TxR  panel).  Identical  results  were  ob- 
tained when endosomes were loaded by shorter periods of 
culture with TxR or SR101 (not shown). 
Class  II-containing compartments  are  situated  late  in 
the endocytic pathway (31, 32). To analyze whether the 
rapidly moving  13-GFP  containing vesicles were  able  to 
transport endocytosed material as well, cells were allowed 
to internalize the red fluorochrome SR101 for 30 min and 
then cultured for an additional 30 min in the absence of 
SR101 (Fig. 5 C); cells were analyzed as in Fig. 5 B. SR101- 
labeled  late  endocytic  structures  displayed  a  different 
morphology from  those  labeled  by  shorter  incubations 
(see Fig. 5 B), and now resemble the intracellular distribu- 
tion of class II/[3-GFP containing vesicles. When the iden- 
tical analysis, as in Fig 5 A, was performed, rapidly moving 
vesicles (yellow) were observed that contained both class 
II/13-GFP and SR101. Apparently, (a fraction of) endocy- 
tosed material can be regurgitated after long periods of in- 
ternalization. Since 13-GFP does not colocalize with early 
endosomal structures (Fig. 5 B), this transport route is dif- 
ferent from recycling early endosomes. 
To  analyze  whether  the  migrating  13-GFP  containing 
vesicles remain acidic, cells were incubated with LysoTracker 
Red, a membrane diffusable red fluorochrome that accu- 
mulates in acidic compartments, and the cells were ana- 
lyzed as in Fig. 5 B. All class II/~-GFP containing vesicles, 
including  those  moving  (shown  in  yellow),  accumulated 
LysoTracker indicating  that  they  are  acidic  (Fig.  5  D). 
Note  the  presence  of  vesicles  exclusively  labeled  with 
LysoTracker, consistent with earlier observations that late 
lysosomes are devoid of class II molecules (13, 31). 
Fusion of Class IIIfl-GFP Containing  Vesicles with the 
Plasma Membrane 
To  visualize  fusion  of the  fluorescent vesicles  with  the 
plasma membrane, images of the transfectants cultured at 
37°C were made at 2-s intervals. Fig. 6 A  shows part of a 
cell with plasma membrane fluorescence and some rapidly 
migrating  peripheral  vesicles.  Arrows  denote  a  vesicle 
moving towards the plasma membrane (at t =  0 and 2 s), 
incorporating in the membrane fluorescence (at t  =  4, 6 
and 8 s) and finally disappearing (at t =  10 s). 
However, the resolution of confocal microscopy is insuf- 
ficient to visualize the details of fusion of the class 11/6  - 
GFP containing compartments. Electron microscopy may 
give sufficient details of this process but requires distinc- 
tion between fusion of secretory class II--containing vesi- 
cles and internalization. Hence, sections were stained with 
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by confocal microscopy and images were collected every 2 s. Only part of a cell is shown with some plasma membrane labeling and a 
number of peripheral vesicles. Part of a perinuclear region of a neighboring  cell is visible at the left side of the figure. The arrow denotes 
a vesicle that is moving to the plasma membrane (t = 0 and 2 s), associating with the membrane fluorescence (t = 4, 6, and 8 s) and fi- 
nally disappearing (t = 10 s). (B) 13-GFP-transfected cells were fixed and cryosections were labeled with anti-CD63 (5 nm gold) and anti- 
class II 13 chain (10 nm gold).  Multivesicular compartments (large thick arrows) containing class II 13 chain and CD63 are shown that 
have fused with the plasma membrane. In A and C, arrowheads point at the continuity  of the plasma membrane with the vesicular mem- 
brane. The surface membrane (m) close to the fused vesicles is labeled for CD63 (small arrows). In C, several multivesicular compart- 
ments containing  class I113 chain and CD63 are shown (v) near the cell surface. The marked multivesicular  compartment contains class 
II (middle size arrow) and CD63 (small arrows). It has fused with the plasma membrane and its lumen is clearly open to the intercellular 
space. (Optical sections: 2 txm; Bar, [A] 5 Ixm.) Bars, 100 nm. 
antibodies against the  class II 13  chain and CD63.  Since 
CD63  is  abundantly present in class  II-containing com- 
partments, but hardly expressed at the plasma membrane, 
a fusing vesicle should contain CD63, although this marker 
protein should rarely be present in endocytic vesicles. Fig. 
6 B  shows three fusion events of vesicles containing both 
class II molecules (large gold) and CD63 (small gold). The 
upper panel shows  some  CD63  labeling at  the  acceptor 
plasma membrane around the site of fusion. Since CD63 
labeling is not observed at the plasma membrane, this sug- 
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vesicle onto the  plasma  membrane.  All observed fusing 
vesicles contained both  CD63  and  class  II molecules in 
agreement  with  a  recent  report  showing  multivesicular 
compartments fusing with the plasma membrane (37). 
Discussion 
MHC class II molecules enter the endocytic route to asso- 
ciate with peptide fragments derived from degraded pro- 
teins before cell surface appearance. The class II-associ- 
ated invariant chain (Ii) targets class II molecules to the 
endocytic pathway either by sorting in the trans-Golgi net- 
work or by internalization from the plasma membrane. In 
endocytic vesicles, Ii is degraded which is an essential step 
that precedes peptide loading of class II molecules and 
release from the endocytic pathway (7, 8, 44). The exact 
endocytic location where peptide loading of class II mole- 
cules occurs, has been a matter of debate. Immuno-elec- 
tron  microscopy showed  class  II  molecules in  so-called 
MIIC compartments with a multivesicular or multilamel- 
lar morphology that contain many lysosomal marker pro- 
teins (31, 32, 15). Some, but not all, epitopes of Ii could be 
observed in these structures suggesting that Ii-degradation 
occurs in MIIC (32). Subcellular fractionation experiments 
have  observed class  II molecules in  transferrin-receptor 
containing endosomes (1), middle endosomes (50), and ly- 
sosomes (36, 54), and thus confused an unequivocal deter- 
mination of the intracellular site of peptide loading of class 
II molecules. Recently, a molecule, HLA-DM, has been 
identified that supports proper peptide loading of class II 
molecules (11, 4I, 47, 48.). HLA-DM therefore is a better 
indicator for the intracellular site of class II-peptide load- 
ing and has been observed in MIIC structures in EBV- 
transformed B cells by immuno-electron microscopy (32, 42). 
In this study, we have followed transport of MHC class II 
in the melanoma cell line Mel JuSo because its intracellu- 
lar distribution and transport of class II molecules is exten- 
sively studied (33, 50, 51, 56). Using subcellular fraction- 
ation, we recently established for this cell line that class II 
molecules and  HLA-DM are  expressed in  early or low 
density lysosomes and that early and middle endosomes 
are devoid of class II molecules, HLA-DM and cathepsin 
D  (13), The intracettutar distribution of class II/I3-GFP is 
identical to endogenous class II molecules and class II/[3- 
GFP accumulates in lysosomal structures with all charac- 
teristics of MIIC. We have not identified structures corre- 
sponding to CIIV (which should have contained TfR) in 
these cells (Fig. 3 E, see reference 13). 
How class II molecules are transported from these early 
lysosomal MIIC-like compartments to the plasma  mem- 
brane is unknown and no similar pathway (i.e. from lyso- 
somes to the plasma membrane) has been visualized. MHC 
class II molecules could be transported in a  retrograde 
endosomal pathway or they may be transported directly 
from MIIC to the plasma membrane. Experiments com- 
bining pulse chase experiments with subcellular fraction- 
ations have not been successful in elucidating this prob- 
lem. Here, we have visualized class II molecules in living 
cells. The addition of GFP onto the cytoplasmic tail of the 
class II [3 chain does not affect normal intracellular distri- 
bution, assembly of the class II complex, and peptide load- 
ing. In addition, the timing of peptide loading is identical 
to that of endogenous class II molecules (data not shown) 
suggesting no major effects of GFP addition on entry into 
class II-loading compartments. Apparently, addition of the 
fluorochrome did not interfere with the sorting signals of 
the invariant chain/MHC class II complex (2, 34, 3, 28, 6, 35). 
We have subsequently followed transport of these vesi- 
cles in  real time.  This  allowed  visualization of a  direct 
rapid transport pathway of acidic class II--containing vesi- 
cles towards the plasma  membrane.  Since these vesicles 
are accessible to fluid phase markers only after uptake pe- 
riods longer than 45 min, they should correspond to late 
endosomal/lysosomal structures.  Fusing  class  II  vesicles 
contain the lysosomal marker CD63 indicating that these 
are also lysosomal structures that lack detectable Ii (not 
shown). The transport route from lysosomal structures to 
the plasma membrane, as used by MHC class II molecules, 
is distinct from the endocytic route because: (a) migrat- 
ing 13-GFP containing vesicles do not fuse with endosomes 
labeled  by 24  min  endocytosis of TxR;  (b)  these  endo- 
somes  have  a  morphology  different  from  the  moving 
13-GFP-containing vesicles; and (c) the rate of transport of 
13-GFP  containing  vesicles  is  considerably  faster  (esti- 
mated at ,'-5 l~m/min) than endosomal transport (endoso- 
mal structures hardly alter within the 1-min timespan [see 
Fig. 5 B] and move with ~q).5 ixm/min [9]). This transport 
process involves microtubuli since nocodazole and colce- 
mid block the movement of the fluorescent vesicles (not 
shown). 
Although fusion of class II-containing vesicles with the 
plasma  membrane can be  visualized, it remains  unclear 
how the internal membranes observed in these vesicles are 
incorporated in the plasma membrane. Recently, a mecha- 
nism  was  suggested where part  of the  vesicles were se- 
creted (so called exosomes, reference 37). The exposed lu- 
minal portion of class II was suggested to confer antigen 
presenting capacities to these vesicles. In addition, a shut- 
tle theory was proposed to allow neighboring cells to take 
up exosomes. The latter is  not observed at a  detectable 
level in our cells since cells that lost expression of the class 
II/GFP chimeras failed to obtain class II molecules from 
the surrounding cells. 
Since class II molecules are rapidly and directly trans- 
ported  from  lysosomal  structures  to  the  plasma  mem~ 
brane, they do not interact with antigen generated in earlier 
endosomal structures. Since early and middle endosomes 
of Mel JuSo cells lack cathepsin D, HLA-DM, and pepti- 
dase activity (13, 42), antigen uptake in earlier endosomes 
would have been inefficient anyway. Finally, endocytosed 
material can use the route used by class II molecules for 
surface appearance to become secreted back to the me- 
dium, as suggested here for SR101  (Fig. 5 C) and as ob- 
served for internalized HRP (not shown). This offers the 
possibility that a  fraction of antigenic peptide fragments 
generated in the endosomal/lysosomal pathway is able to 
load plasma membrane-embedded class I and II molecules 
upon secretion. Because the  efficiency of this process is 
unclear, it may occur only when large quantities of antigen 
are internalized. 
The existence of a transport route from lysosomes to the 
plasma membrane has been suggested before on the basis 
of the resistance to chloroquine of surface deposition of 
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of MIIC-derived vesicles associated with the plasma mem- 
brane and in the medium (37). Here we directly visualized 
the  existence  of  such  a  transport  route  that is  used  by 
MHC  class  II  molecules  in  the  melanoma  cell  line  Mel 
JuSo. The existence of a corresponding pathway in profes- 
sional antigen presenting cells remains to be shown. Direct 
transport from lysosomal structures  to the plasma  mem- 
brane has some remarkable similarities with the process of 
regulated  secretion  as observed  for example  by cytolytic 
granules in  CTLs  (18,30).  These  granules  also  contain a 
number of lysosomal markers but the release of their con- 
tent is tightly regulated.  In contrast, transport of class  II 
molecules to the plasma membrane appears to be constitu- 
tive  although  it  requires  efficient  degradation  of  the  Ii 
chain (25, 56) and may be altered in activated DC (27, 40). 
The processes  that determine the release of class II-con- 
taining  vesicles  from  the  perinuclear  region  and  their 
transport  to  the  plasma  membrane  remain  to  be  estab- 
lished. 
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